The EPO published patent application EP4370179A1 for SHL Medical AG's injection support pad, covering a medical device to assist patients with self-injections. The invention relates to support mechanisms for injection devices and is classified under A61M 5/42, 5/20, 5/24, 5/32, and 5/158. The patent is valid in designated European states including Germany, France, UK, Italy, Spain, and 27 other countries. Applicant: SHL Medical AG. Inventors: Stefanov, Ali, Scott, and Demirozer. Published March 25, 2026.\n\nThis is a patent grant publication, not a regulatory compliance requirement. Compliance teams should note this patent establishes prior art in the injection support device space. Companies developing similar self-injection support products for the European market should evaluate whether their products infringe EP4370179A1 and consider licensing or design-around strategies. No immediate regulatory action or compliance deadline applies to this publication notice.